skip to main content
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
HER2/neu incidence in early breast cancer and its correlation with others prognostic factors
Material Type:
Artigo
Adicionar ao Meu Espaço

HER2/neu incidence in early breast cancer and its correlation with others prognostic factors

Molina Barrios, G. R. ; Lavarda, M. ; Rizzi, M. L. ; Dubersarsky, C. ; Jarchum, G. D.

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.22195-22195 [Periódico revisado por pares]

Texto completo disponível

2
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
Material Type:
Artigo
Adicionar ao Meu Espaço

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline

Rathmell, W. Kimryn ; Rumble, R. Bryan ; Van Veldhuizen, Peter J. ; Al-Ahmadie, Hikmat ; Emamekhoo, Hamid ; Hauke, Ralph J. ; Louie, Alexander V. ; Milowsky, Matthew I. ; Molina, Ana M. ; Rose, Tracy L. ; Siva, Shankar ; Zaorsky, Nicholas G. ; Zhang, Tian ; Qamar, Rubina ; Kungel, Terry M. ; Lewis, Bryan ; Singer, Eric A.

Journal of clinical oncology, 2022-09, Vol.40 (25), p.2957-2995 [Periódico revisado por pares]

Texto completo disponível

3
Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

ADJEI, Alex A ; MANDREKAR, Sumithra J ; ZINNER, Ralph G ; DY, Grace K ; MOLINA, Julian R ; ADJEI, Araba A ; GANDARA, David R ; ALLEN ZIEGLER, Katie L ; STELLA, Philip J ; ROWLAND, Kendrith M ; SCHILD, Steven E

Journal of clinical oncology, 2010-02, Vol.28 (4), p.614-619 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

4
Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry
Material Type:
Artigo
Adicionar ao Meu Espaço

Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry

Drilon, Alexander ; Duruisseaux, Michael ; Han, Ji-Youn ; Ito, Masaoki ; Falcon, Christina ; Yang, Soo-Ryum ; Murciano-Goroff, Yonina R ; Chen, Haiquan ; Okada, Morihito ; Molina, Miguel Angel ; Wislez, Marie ; Brun, Philippe ; Dupont, Clarisse ; Branden, Eva ; Rossi, Giulio ; Schrock, Alexa ; Ali, Siraj ; Gounant, Valérie ; Magne, Fanny ; Blum, Torsten Gerriet ; Schram, Alison M ; Monnet, Isabelle ; Shih, Jin-Yuan ; Sabari, Joshua ; Pérol, Maurice ; Zhu, Viola W ; Nagasaka, Misako ; Doebele, Robert ; Camidge, D Ross ; Arcila, Maria ; Ou, Sai-Hong Ignatius ; Moro-Sibilot, Denis ; Rosell, Rafael ; Muscarella, Lucia Anna ; Liu, Stephen V ; Cadranel, Jacques

Journal of clinical oncology, 2021-09, Vol.39 (25), p.2791-2802 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

5
Use of immunotherapy for stage-III and IV melanoma and likelihood of regional and distant lymph node resection and surgical resection for distant metastasis
Material Type:
Artigo
Adicionar ao Meu Espaço

Use of immunotherapy for stage-III and IV melanoma and likelihood of regional and distant lymph node resection and surgical resection for distant metastasis

Molina, George ; Kasumova, Gyulnara G. ; Qadan, Motaz ; Boland, Genevieve Marie

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9558-9558 [Periódico revisado por pares]

Texto completo disponível

6
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study
Material Type:
Artigo
Adicionar ao Meu Espaço

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study

Taplin, Mary-Ellen ; Montgomery, Bruce ; Logothetis, Christopher J ; Bubley, Glenn J ; Richie, Jerome P ; Dalkin, Bruce L ; Sanda, Martin G ; Davis, John W ; Loda, Massimo ; True, Lawrence D ; Troncoso, Patricia ; Ye, Huihui ; Lis, Rosina T ; Marck, Brett T ; Matsumoto, Alvin M ; Balk, Steven P ; Mostaghel, Elahe A ; Penning, Trevor M ; Nelson, Peter S ; Xie, Wanling ; Jiang, Zhenyang ; Haqq, Christopher M ; Tamae, Daniel ; Tran, NamPhuong ; Peng, Weimin ; Kheoh, Thian ; Molina, Arturo ; Kantoff, Philip W

Journal of clinical oncology, 2014-11, Vol.32 (33), p.3705-3715 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

7
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Material Type:
Artigo
Adicionar ao Meu Espaço

Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

Ghesquieres, Hervé ; Slager, Susan L ; Jardin, Fabrice ; Veron, Amelie S ; Asmann, Yan W ; Maurer, Matthew J ; Fest, Thierry ; Habermann, Thomas M ; Bene, Marie C ; Novak, Anne J ; Mareschal, Sylvain ; Haioun, Corinne ; Lamy, Thierry ; Ansell, Stephen M ; Tilly, Herve ; Witzig, Thomas E ; Weiner, George J ; Feldman, Andrew L ; Dogan, Ahmet ; Cunningham, Julie M ; Olswold, Curtis L ; Molina, Thierry Jo ; Link, Brian K ; Milpied, Noel ; Cox, David G ; Salles, Gilles A ; Cerhan, James R

Journal of clinical oncology, 2015-11, Vol.33 (33), p.3930-3937 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

8
Prospective BASECAMP-1 experience in patients with gastrointestinal (GI) cancer: Identifying patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) for a future therapeutic trial exploiting LOH as a tumor vulnerability
Material Type:
Artigo
Adicionar ao Meu Espaço

Prospective BASECAMP-1 experience in patients with gastrointestinal (GI) cancer: Identifying patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) for a future therapeutic trial exploiting LOH as a tumor vulnerability

Hecht, J. Randolph ; Kopetz, Scott ; Welling, Theodore ; Morelli, Maria Pia ; Molina, Julian R. ; Kirtane, Kedar ; Oberstein, Paul Eliezer ; Greenwald, Daniel R. ; Lin, Yi ; Mardiros, Armen ; Beutner, Karl ; Lozac'hmeur, Ariane ; Salahudeen, Ameen ; Liechty, Kirstin B. ; Vong, Judy ; Ng, Eric Wai-Choi ; Maloney, David G. ; Go, William Y. ; Welch, John Sutton ; Simeone, Diane M.

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.209-209 [Periódico revisado por pares]

Texto completo disponível

9
BASECAMP-1: Leveraging human leukocyte antigen (HLA) loss of heterozygosity (LOH) in solid tumors by next-generation sequencing (NGS) to identify patients with relapsed solid tumor for future logic-gated Tmod CAR T-cell therapy
Material Type:
Artigo
Adicionar ao Meu Espaço

BASECAMP-1: Leveraging human leukocyte antigen (HLA) loss of heterozygosity (LOH) in solid tumors by next-generation sequencing (NGS) to identify patients with relapsed solid tumor for future logic-gated Tmod CAR T-cell therapy

Simeone, Diane M. ; Hecht, J. Randolph ; Patel, Sandip Pravin ; Morelli, Maria Pia ; Kirtane, Kedar ; Borad, Mitesh J. ; Maus, Marcela Valderrama ; Sunwoo, John B. ; Welling, Theodore ; Lin, Yi ; Garon, Edward B. ; Kopetz, Scott ; Locke, Frederick L. ; Liechty, Kirstin B. ; Lozac'hmeur, Ariane ; Beutner, Karl ; Ng, Eric Wai-Choi ; Go, William Y. ; Maloney, David G. ; Molina, Julian R.

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS2676-TPS2676 [Periódico revisado por pares]

Texto completo disponível

10
Phase II randomized double blind trial of axitinib (Axi) +/- PF-04518600, an OX40 antibody (PFOX) after PD1/PDL1 antibody (IO) therapy (Tx) in metastatic renal cell carcinoma (mRCC)
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II randomized double blind trial of axitinib (Axi) +/- PF-04518600, an OX40 antibody (PFOX) after PD1/PDL1 antibody (IO) therapy (Tx) in metastatic renal cell carcinoma (mRCC)

Sadeghi, Sarmad ; Parikh, Rahul Atul ; Tsao-Wei, Denice D. ; Groshen, Susan G. ; Li, Ming ; Appleman, Leonard Joseph ; Tagawa, Scott T. ; Nanus, David M. ; Molina, Ana M. ; Kefauver, Cheryl ; Ornstein, Moshe Chaim ; Rini, Brian I. ; Dreicer, Robert ; Quinn, David I. ; Lara, Primo "Lucky" N.

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4529-4529 [Periódico revisado por pares]

Texto completo disponível

Resultados 1 2 3 4 5 next page

Buscando em bases de dados remotas. Favor aguardar.